{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T13:26:15Z","timestamp":1774358775798,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.lungcan.2008.10.019","type":"journal-article","created":{"date-parts":[[2008,12,4]],"date-time":"2008-12-04T11:24:18Z","timestamp":1228389858000},"page":"74-79","source":"Crossref","is-referenced-by-count":14,"title":["A phase I study of combination S-1 plus cisplatin chemotherapy with concurrent thoracic radiation for locally advanced non-small cell lung cancer"],"prefix":"10.1016","volume":"65","author":[{"given":"Kenichi","family":"Chikamori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daizo","family":"Kishino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagio","family":"Takigawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuyuki","family":"Hotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoyuki","family":"Nogami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruhito","family":"Kamei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoichi","family":"Kuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Gemba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiro","family":"Takemoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susumu","family":"Kanazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Ueoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiko","family":"Segawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saburo","family":"Takata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Tabata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuyuki","family":"Kiura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsune","family":"Tanimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2008.10.019_bib1","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1200\/JCO.1996.14.4.1055","article-title":"Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: radiation therapy oncology group protocol 91-06","volume":"14","author":"Lee","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2008.10.019_bib2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0360-3016(96)00087-9","article-title":"Concurrent cisplatin, etoposide, and radiotherapy for unresectable stage III nonsmall cell lung cancer: a phase II study","volume":"35","author":"Reboul","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.lungcan.2008.10.019_bib3","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1054\/bjoc.1999.0885","article-title":"A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group","volume":"82","author":"Segawa","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/j.lungcan.2008.10.019_bib4","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/00001813-199607000-00010","article-title":"Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators","volume":"7","author":"Shirasaka","year":"1996","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.lungcan.2008.10.019_bib5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00280-005-0150-0","article-title":"Potassium oxonate, an enzyme inhibitor compounded in S-1, reduces the suppression of antitumor immunity induced by 5-fluorouracil","volume":"58","author":"Yamashita","year":"2006","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.lungcan.2008.10.019_bib6","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1054\/bjoc.2001.2031","article-title":"Phase II study of S-1, a novel oral fluorouracil, in advanced non-small-cell lung cancer","volume":"85","author":"Kawahara","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.lungcan.2008.10.019_bib7","doi-asserted-by":"crossref","first-page":"7860","DOI":"10.1158\/1078-0432.CCR-04-1200","article-title":"S-1 plus cisplatin combination chemotherapy in patients with advanced non-small cell lung cancer: a multi-institutional phase II trial","volume":"10","author":"Ichinose","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.lungcan.2008.10.019_bib8","first-page":"1079","article-title":"Combination cytotoxic effects of cis-diamminedichloroplatinum(II) and 5-fluorouracil with and without leucovorin against human non-small cell lung cancer cell lines","volume":"53","author":"Tsai","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.lungcan.2008.10.019_bib9","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1158\/1541-7786.MCR-04-0032","article-title":"Cisplatin sensitizes cancer cells to ionizing radiation via inhibition of nonhomologous end joining","volume":"3","author":"Boeckman","year":"2005","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.lungcan.2008.10.019_bib10","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1200\/JCO.1990.8.5.911","article-title":"Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors","volume":"8","author":"Vokes","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2008.10.019_bib11","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0959-8049(01)00363-X","article-title":"The combined use of radiotherapy and chemotherapy in the treatment of solid tumours","volume":"38","author":"Bartelink","year":"2002","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.lungcan.2008.10.019_bib12","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.oraloncology.2004.01.013","article-title":"Combined effects of the oral fluoropyrimidine anticancer agent S-1 and radiation on human oral cancer cells","volume":"40","author":"Harada","year":"2004","journal-title":"Oral Oncol"},{"key":"10.1016\/j.lungcan.2008.10.019_bib13","first-page":"465","article-title":"S-1 an oral fluoropyrimidine, enhances radiation response of DLD-1\/FU human colon cancer xenografts resistant to 5-FU","volume":"16","author":"Nakata","year":"2006","journal-title":"Oncol Rep"},{"key":"10.1016\/j.lungcan.2008.10.019_bib14","series-title":"ECCO 13\u2014The European Cancer Conference, vol. 3","first-page":"343","article-title":"Combined therapy with radiation and S-1, an oral new 5FU prodrug, is markedly effective against non-small cell lung cancer xenografts in mice","author":"Fukushima","year":"2005"},{"key":"10.1016\/j.lungcan.2008.10.019_bib15","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/sj.bjc.6602804","article-title":"Randomized scheduling feasibility study of S-1 for adjuvant chemotherapy in advanced head and neck cancer","volume":"93","author":"Tsukuda","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.lungcan.2008.10.019_bib16","doi-asserted-by":"crossref","unstructured":"Tahara M, Minami H, Mukai H, Kawada K, Kawashima M, Ogino T, Yamazaki M, et al. Phase I study of concurrent chemoradiotherapy (CRT) with S-1 and cisplatin (CDDP) in patients (pts) with unresectable locally advanced squamous cell carcinoma of head and neck (SCCHN). Proceeding of ASCO meeting, vol. 23, 2005: 5575.","DOI":"10.1200\/jco.2005.23.16_suppl.5575"},{"key":"10.1016\/j.lungcan.2008.10.019_bib17","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/sj.bjc.6601217","article-title":"Phase I\/II study of docetaxel and cisplatin with concurrent thoracic radiation therapy for locally advanced non-small-cell lung cancer","volume":"89","author":"Kiura","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.lungcan.2008.10.019_bib18","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1378\/chest.111.6.1710","article-title":"Revisions in the international system for staging lung cancer","volume":"111","author":"Mountain","year":"1997","journal-title":"Chest"},{"key":"10.1016\/j.lungcan.2008.10.019_bib19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.lungcan.2008.10.019_bib20","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1200\/JCO.1993.11.11.2136","article-title":"Concurrent radiation therapy and chemotherapy for locally unresectable squamous cell head and neck cancer: an Eastern Cooperative Oncology Group pilot study","volume":"11","author":"Adelstein","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2008.10.019_bib21","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S1053-4296(97)80026-4","article-title":"Radiation Therapy With 5-fluorouracil in Head and Neck Cancer","volume":"7","author":"Fu","year":"1997","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.lungcan.2008.10.019_bib22","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF00685830","article-title":"Metabolic basis of the synergistic antitumor activities of 5-fluorouracil and cisplatin in rodent tumor models in vivo","volume":"32","author":"Shirasaka","year":"1993","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.lungcan.2008.10.019_bib23","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00001813-200402000-00001","article-title":"The modulated oral fluoropyrimidine prodrug S-1, and its use in gastrointestinal cancer and other solid tumors","volume":"15","author":"Schoffski","year":"2004","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.lungcan.2008.10.019_bib24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.lungcan.2004.03.004","article-title":"Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study","volume":"46","author":"Zatloukal","year":"2004","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2008.10.019_bib25","doi-asserted-by":"crossref","first-page":"5883","DOI":"10.1200\/JCO.2005.55.405","article-title":"Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small-cell lung cancer: a randomized phase II locally advanced multi-modality protocol","volume":"23","author":"Belani","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2008.10.019_bib26","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1200\/JCO.2006.07.3569","article-title":"Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III Non-small-cell lung cancer: Cancer and Leukemia Group B","volume":"25","author":"Vokes","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2008.10.019_bib27","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1200\/JCO.1999.17.9.2692","article-title":"Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer","volume":"17","author":"Furuse","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2008.10.019_bib28","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0360-3016(99)00183-2","article-title":"Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC)","volume":"45","author":"Graham","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.lungcan.2008.10.019_bib29","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/sj.bjc.6603422","article-title":"Second primary cancer in survivors following concurrent chemoradiation for locally advanced non-small-cell lung cancer","volume":"95","author":"Takigawa","year":"2006","journal-title":"Br J Cancer"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500208005618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500208005618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T00:07:05Z","timestamp":1557965225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500208005618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S0169500208005618"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2008.10.019","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}